Aclaris Therapeutics, Inc. Cash Flow Statement

Cash Flow Statement Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -5.24M-8.52M-20.56M-48.08M-18.06M-50.63M-47.81M0.14M-90.86M-86.91M-88.48M-132.06M
Depreciation and Depletion 0.01M0.01M0.09M0.12M0.37M1.20M1.50M1.10M0.80M0.70M0.80M0.70M
Share-based Compensation 0.03M0.89M6.10M14.43M20.05M16.18M11.21M14.06M15.04M20.54M10.86M
Deferred Taxes -1.84M-0.18M-0.37M
Gains from Sales and Divestitures 0.04M0.14M0.17M1.80M1.34M0.53M0.75M1.47M
Gains from Investment Securities 2.35M3.33M4.28M3.10M2.87M3.79M5.17M6.42M6.72M
Asset Writedowns and Impairment 0.29M0.22M27.64M6.63M
Cash from Restructuring 2.78M
Non-cash Items 19.81M2.40M0.15M4.89M13.71M15.29M0.01M10.00M
Cash from Operations -4.92M-7.64M-20.37M-34.60M-54.66M-100.81M-96.44M-38.63M-52.13M-67.57M-78.33M-20.07M
Depreciation, Depletion & Amortization
Amortization of Goodwill 18.50M
Amortization of Deferred Charges 0.00M0.00M
Depreciation & Amortization (CF) 0.01M0.01M0.09M0.12M0.40M1.88M6.41M1.32M0.92M0.80M0.86M0.81M
Change in Working Capital
Change in Receivables 4.38M0.81M-4.90M-0.15M-0.14M-0.19M0.02M
Change in Inventory -0.10M-0.60M
Change in Account Payables 0.30M0.82M-0.36M1.81M4.56M6.96M-3.16M-5.22M3.65M0.37M-1.47M-4.19M
Change in Accured Expenses -0.01M0.17M0.55M2.45M0.61M6.79M-1.97M-3.73M0.47M0.59M11.99M-3.94M
Investing Activities
Capital Expenditures 0.42M0.51M0.23M1.24M1.36M1.61M0.45M0.31M0.60M1.31M0.12M
Change in Intangibles 35.81M
Acquisitions 9.65M
Change in Acquisitions & Divestments 3.67M6.07M87.09M152.53M239.44M210.49M54.55M67.83M177.99M183.20M86.14M
Cash from Investing Activities -4.54M-1.78M-76.95M-61.90M-55.69M9.37M105.68M6.39M-167.63M12.63M46.22M-69.77M
Financing Activities
Other financing activities 0.00M-0.06M-0.05M-0.04M0.21M-1.57M-0.01M-0.38M
Debt Issuance and Repayment
Long-Term Debt Issuances 29.91M10.91M
Long-Term Debt Repayments 0.08M0.65M-30.00M-11.48M
Change in Capital Stock
Shares Issued 56.55M0.12M0.23M0.58M0.21M0.07M1.46M72.74M26.71M74.91M
Preferred Shares Issued 10.58M39.86M
Misc.
Cash from Financing Activities 10.58M96.41M116.83M100.39M128.26M-30.32M18.37M225.05M72.87M26.71M74.54M
Change in Cash -9.46M1.17M-0.91M20.32M-9.97M36.82M-21.08M-13.87M5.29M17.93M-5.40M-15.31M
Free Cash Flow -4.92M-8.05M-20.88M-34.84M-55.90M-102.17M-98.06M-39.09M-52.44M-68.17M-79.63M-20.20M
Net Cash Flow -9.46M1.17M-0.91M20.32M-9.97M36.82M-21.08M-13.87M5.29M17.93M-5.40M-15.31M